Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study
Clinical trial NCT07179939 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07179939
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-10
- Primary completion
- 2030-12-30
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.